You have 9 free searches left this month | for more free features.

clopidogrel combined with ASA

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronary Artery Disease, Myocardial Infarction Trial in Ottawa (Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81

Suspended
  • Coronary Artery Disease
  • Myocardial Infarction
  • Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
  • +2 more
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Feb 17, 2022

Antiplatelet Therapies in Depression and Coronary Disease

Recruiting
  • Coronary Artery Disease
  • Depression
  • standard Aspirin (ASA) + clopidogrel (CLP) therapy
  • +2 more
  • Milan, Italy
  • +1 more
Apr 6, 2023

Ischemic Stroke Trial in Guangzhou (Aspirin, Clopidogrel, Alteplase)

Not yet recruiting
  • Ischemic Stroke
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Jun 11, 2023

Stroke, Transient Ischemic Attack Trial in Beijing (Clopidogrel, Placebo of clopidogrel and Asprin)

Completed
  • Stroke
  • Transient Ischemic Attack
  • Beijing, China
    Beijing Tian Tan Hospital, Capital Medical University
Jul 13, 2020

Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)

Not yet recruiting
  • Exclusive Enteral Nutrition
  • +2 more
  • exclusive enteral nutrition
  • regular food
  • (no location specified)
Dec 5, 2022

Thrombosis Trial in Nanjing (Aspirin?clopidogrel? or SHR2285, Aspirin?ticagrelor? or SHR2285)

Completed
  • Thrombosis
  • Aspirin、clopidogrel、placebo or SHR2285
  • Aspirin、ticagrelor、placebo or SHR2285
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Jun 30, 2022

Head Neck Cancer Trial in Charleston (Pembrolizumab, Clopidogrel, acetylsalicylic acid)

Recruiting
  • Head and Neck Cancer
  • Charleston, South Carolina
    Medical University of South Carolina
Dec 22, 2022

Cerebrovascular Accident, Cerebrovascular Accident, Acute Trial in Beijing (ticagrelor + ASA, Placebo+ASA)

Completed
  • Cerebrovascular Accident
  • Cerebrovascular Accident, Acute
  • ticagrelor + ASA
  • Placebo+ASA
  • Beijing, China
    Peking University Third Hospital
Jul 4, 2021

Acute Coronary Syndrome Trial in Montreal (Ticagrelor 90mg, Clopidogrel 75mg, acetylsalicylic acid (ASA) 81mg)

Active, not recruiting
  • Acute Coronary Syndrome
  • Ticagrelor 90mg
  • +2 more
  • Montreal, Quebec, Canada
    McGill University Health Centre
Apr 14, 2021

SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)

Recruiting
  • SCAD
  • AMI
  • Sao Paulo, Brazil
    Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
Nov 4, 2021

Aortic Valve Stenosis Trial in Athens (Ticagrelor plus ASA, Clopidogrel plus ASA)

Completed
  • Aortic Valve Stenosis
  • Ticagrelor plus ASA
  • Clopidogrel plus ASA
  • Athens, Greece
    1st Department of Cardiology, Hippokration Hospital
Mar 1, 2021

Stroke, Transient Ischemic Attack Trial in China (Ticagrelor and Aspirin, Clopidogrel and Aspirin)

Recruiting
  • Acute Nondisabling Ischemic Stroke
  • Transient Ischemic Attack
  • Tagrelor combined with aspirin
  • Clopidogrel combined with aspirin
  • Beijing, China
    Peking University Third Hospital
Jun 27, 2021

Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +

Not yet recruiting
  • Coronary Artery Disease
  • +2 more
  • Aspirin + Clopidogrel + Rivaroxaban
  • Aspirin + Clopidogrel
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences, Fuwai Hospital
Dec 5, 2022

Rivaroxaban Trial (clopidogrel combined with rivaroxaban arm)

Not yet recruiting
  • Rivaroxaban
  • clopidogrel combined with rivaroxaban arm
  • (no location specified)
Mar 16, 2021

Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality Trial in Brazil (JUVÉDERM, BOTOX, HArmonyCA Lidocaine)

Not yet recruiting
  • Facial Rhytides
  • +2 more
  • JUVÉDERM
  • +2 more
  • Brasilia, Brazil
  • +6 more
Jan 25, 2023

Stable Chronic Angina Trial in Shiraz (Clopidogrel, Ticagrelor)

Completed
  • Stable Chronic Angina
  • Shiraz, Iran, Islamic Republic of
    Professor Kojuri Cardiology Clinic
May 12, 2023

Peripheral Arterial Disease Trial in Denver, Davenport, Dallas (Clopidogrel, Acetylsalicylic acid (ASA))

Completed
  • Peripheral Arterial Disease
  • Denver, Colorado
  • +3 more
Feb 1, 2021

Critical Limb Ischemia Trial in São Paulo (Apixaban, ASA, Clopidogrel 75mg)

Recruiting
  • Critical Limb Ischemia
  • São Paulo, Brazil
    IAMSPE - Sao Paulo Public Servants Hospital
Apr 17, 2021

Left Atrial Appendage Occlusion Trial in Barcelona (Apixaban vs. DAPT)

Completed
  • Left Atrial Appendage Occlusion
  • Apixaban vs. DAPT
  • Barcelona, Spain
    Hospital Clinic Barcelona
Nov 21, 2022

Left Ventricular Assist Device Patients

Completed
  • End-stage Heart Failure
  • +2 more
  • VerifyNow antiplatelet therapy response test
  • Vienna, Austria
    Medical University of Vienna
Nov 28, 2023

Cryptogenic Ischemic Stroke, Patent Foramen Ovale Trial in France (Transcatheter PFO closure, Oral Anticoagulant, Direct-Acting,

Not yet recruiting
  • Cryptogenic Ischemic Stroke
  • Patent Foramen Ovale
  • Transcatheter PFO closure
  • +2 more
  • Amiens, France
  • +30 more
May 20, 2022

Stroke, Transient Ischemic Attack Trial in China (Ticagrelor and Aspirin, Clopidogrel and Aspirin)

Completed
  • Stroke
  • Transient Ischemic Attack
  • Ticagrelor and Aspirin
  • Clopidogrel and Aspirin
  • Anqing, Anhui, China
  • +213 more
Nov 30, 2021

VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests

Active, not recruiting
  • Platelet Aggregation
  • Coronary Artery Disease
    • Jacksonville, Florida
    • +1 more
    Sep 7, 2021

    Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

    Recruiting
    • Clopidogrel, Poor Metabolism of
    • Carotid Stenosis
    • San Donato Milanese, Milan, Italy
      IRCCS Policlinico San Donato
    Sep 30, 2022

    Coronary Artery Disease Trial in Ferrara, Naples (Cangrelor 50 MG)

    Not yet recruiting
    • Coronary Artery Disease
    • Cangrelor 50 MG
    • Ferrara, Italy
    • +1 more
    Oct 13, 2023